SB1495 amends Tennessee opioid laws to include Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. in regulatory provisions.
SB1495 amends Tennessee opioid laws by modifying references to include Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. in regulatory provisions. This change updates the language in Tennessee Code Annotated, Title 20 and Title 33, to ensure these companies are subject to the same regulations as Purdue Pharma L.P. The act includes a severability clause to ensure that invalid provisions do not affect the rest of the law.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.